152 related articles for article (PubMed ID: 3097647)
1. Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect.
Carlstedt-Duke J; Brönnegård M; Strandvik B
Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9202-6. PubMed ID: 3097647
[TBL] [Abstract][Full Text] [Related]
2. Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis.
Strandvik B; Brönnegård M; Gilljam H; Carlstedt-Duke J
Scand J Gastroenterol Suppl; 1988; 143():1-4. PubMed ID: 2455328
[TBL] [Abstract][Full Text] [Related]
3. Effect of dexamethasone on prostaglandin synthesis and on lipocortin status in human endothelial cells. Inhibition of prostaglandin I2 synthesis occurring without alteration of arachidonic acid liberation and of lipocortin synthesis.
Hullin F; Raynal P; Ragab-Thomas JM; Fauvel J; Chap H
J Biol Chem; 1989 Feb; 264(6):3506-13. PubMed ID: 2521636
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid inhibition of zymosan-induced arachidonic acid release by rat alveolar macrophages.
Peters-Golden M; Bathon J; Flores R; Hirata F; Newcombe DS
Am Rev Respir Dis; 1984 Nov; 130(5):803-9. PubMed ID: 6437305
[TBL] [Abstract][Full Text] [Related]
5. Increase of bradykinin-stimulated arachidonic acid release in a delta F508 cystic fibrosis epithelial cell line.
Levistre R; Lemnaouar M; Rybkine T; Béréziat G; Masliah J
Biochim Biophys Acta; 1993 Jun; 1181(3):233-9. PubMed ID: 7686400
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the antiinflammatory and phospholipase-inhibitory activity of calpactin II/lipocortin I.
Northup JK; Valentine-Braun KA; Johnson LK; Severson DL; Hollenberg MD
J Clin Invest; 1988 Oct; 82(4):1347-52. PubMed ID: 2971676
[TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid release from cultured human amnion cells: the effect of dexamethasone.
Potestio FA; Olson DM
J Clin Endocrinol Metab; 1990 Mar; 70(3):647-54. PubMed ID: 1689736
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by glucocorticoids of tumor necrosis factor-mediated cytotoxicity. Evidence against lipocortin involvement.
Beyaert R; Suffys P; Van Roy F; Fiers W
FEBS Lett; 1990 Mar; 262(1):93-6. PubMed ID: 2138568
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis patients' B-lymphocyte response is resistant to the in vitro enhancing effect of corticosteroids.
Emilie D; Crevon MC; Chicheportiche R; Auffredou MT; Barot-Ciorbaru R; Lenoir G; Dayer JM; Galanaud P
Eur J Clin Invest; 1990 Dec; 20(6):620-6. PubMed ID: 1964124
[TBL] [Abstract][Full Text] [Related]
10. The presence of lipocortin in human embryonic skin fibroblasts and its regulation by anti-inflammatory steroids.
Errasfa M; Rothhut B; Fradin A; Billardon C; Junien JL; Bure J; Russo-Marie F
Biochim Biophys Acta; 1985 Nov; 847(2):247-54. PubMed ID: 2933080
[TBL] [Abstract][Full Text] [Related]
11. Effect of mitogen concentration on glucocorticoid suppression of normal and cystic fibrosis lymphocyte activation.
Distelhorst CW; Benutto BM; Corry JM
Cell Immunol; 1983 Jan; 75(1):188-92. PubMed ID: 6825183
[TBL] [Abstract][Full Text] [Related]
12. Release of arachidonic acid from human lymphocytes in response to mitogenic lectins.
Parker CW; Kelly JP; Falkenhein SF; Huber MG
J Exp Med; 1979 Jun; 149(6):1487-503. PubMed ID: 448290
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone-induced stimulation of arachidonic acid release by U937 cells grown in defined medium.
Duval D; Lynde P; Hatzfeld A; Hatzfeld J
Biochim Biophys Acta; 1986 Jul; 887(2):204-13. PubMed ID: 3087432
[TBL] [Abstract][Full Text] [Related]
14. Phospholipid methylation: a biochemical signal modulating lymphocyte mitogenesis.
Hirata F; Toyoshima S; Axelrod J; Waxdal MJ
Proc Natl Acad Sci U S A; 1980 Feb; 77(2):862-5. PubMed ID: 6965797
[TBL] [Abstract][Full Text] [Related]
15. CD2 triggering stimulates a phospholipase A2 activity beside the phospholipase C pathway in human T lymphocytes.
Le Gouvello S; Colard O; Theodorou I; Bismuth G; Tarantino N; Debre P
J Immunol; 1990 Mar; 144(6):2359-64. PubMed ID: 1968928
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of T lymphocyte activation by cyclosporin A: interference with the early activation of plasma membrane phospholipid metabolism.
Szamel M; Berger P; Resch K
J Immunol; 1986 Jan; 136(1):264-9. PubMed ID: 2415622
[TBL] [Abstract][Full Text] [Related]
17. Partial mediation of glucocorticoid antiproliferative effects by lipocortins.
Almawi WY; Saouda MS; Stevens AC; Lipman ML; Barth CM; Strom TB
J Immunol; 1996 Dec; 157(12):5231-9. PubMed ID: 8955167
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis and normal fibroblasts have identical glucocorticoid receptor profiles and induced protein responses.
Khalid BA; Gyorki S; Warne GL; Funder JW
Clin Endocrinol (Oxf); 1983 Apr; 18(4):407-15. PubMed ID: 6872270
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone inhibits receptor-activated phosphoinositide breakdown in rat basophilic leukemia (RBL-2H3) cells.
Berenstein EH; Garcia-Gil M; Siraganian RP
J Immunol; 1987 Mar; 138(6):1914-8. PubMed ID: 2434566
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of glucocorticoid action in pulmonary disease.
Morris HG
Chest; 1985 Aug; 88(2 Suppl):133S-141S. PubMed ID: 2410202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
